These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26412359)

  • 1. Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment.
    Gu X; Ding J; Zhang Z; Li Q; Zhuang X; Chen X
    Curr Pharm Des; 2015; 21(36):5187-97. PubMed ID: 26412359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy.
    González-Fernández Y; Imbuluzqueta E; Patiño-García A; Blanco-Prieto MJ
    Curr Pharm Des; 2015; 21(42):6104-24. PubMed ID: 26503148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes.
    Liang W; Dong Y; Shao R; Zhang S; Wu X; Huang X; Sun B; Zeng B; Zhao J
    J Drug Target; 2022 Jun; 30(5):463-475. PubMed ID: 34962448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.
    Susa M; Iyer AK; Ryu K; Hornicek FJ; Mankin H; Amiji MM; Duan Z
    BMC Cancer; 2009 Nov; 9():399. PubMed ID: 19917123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Bone-targeted Drug Delivery Systems for Neoadjuvant Chemotherapy for Osteosarcoma.
    Li CJ; Liu XZ; Zhang L; Chen LB; Shi X; Wu SJ; Zhao JN
    Orthop Surg; 2016 May; 8(2):105-10. PubMed ID: 27384718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview.
    Desai SA; Manjappa A; Khulbe P
    J Egypt Natl Canc Inst; 2021 Feb; 33(1):4. PubMed ID: 33555490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
    Tanbour R; Martins AM; Pitt WG; Husseini GA
    Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma.
    Huang X; Wu W; Yang W; Qing X; Shao Z
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110891. PubMed ID: 32114271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.
    Shi P; Cheng Z; Zhao K; Chen Y; Zhang A; Gan W; Zhang Y
    J Nanobiotechnology; 2023 Mar; 21(1):103. PubMed ID: 36944946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for high-grade osteosarcoma.
    Hattinger CM; Pasello M; Ferrari S; Picci P; Serra M
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):615-34. PubMed ID: 20690888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric nanoparticles for cancer therapy.
    Parveen S; Sahoo SK
    J Drug Target; 2008 Feb; 16(2):108-23. PubMed ID: 18274932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
    Li S; Xiong Y; Zhang X
    Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
    Olov N; Bagheri-Khoulenjani S; Mirzadeh H
    J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells.
    Gui K; Zhang X; Chen F; Ge Z; Zhang S; Qi X; Sun J; Yu Z
    Biomed Pharmacother; 2019 Mar; 111():751-764. PubMed ID: 30612000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma.
    González-Fernández Y; Brown HK; Patiño-García A; Heymann D; Blanco-Prieto MJ
    Cancer Lett; 2018 Aug; 430():193-200. PubMed ID: 29802930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug.
    Prasad SR; Kumar TSS; Jayakrishnan A
    Nanotechnology; 2018 Jan; 29(1):015101. PubMed ID: 29130895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.